- RecruitingPHASE3
A Study to Compare the Efficacy and Safety of BMS-986353 (Zolacabtagene- Autoleucel / Zola-cel), CD19-CAR T Cells, Versus Standard of Care in Participants With Active Systemic Sclerosis
This study looks at a new treatment called BMS-986353 for severe Systemic Sclerosis. It compares this new treatment with standard care to see if it's more effective and safe for people with this condition.
For: Systemic SclerosisUnited States · Belgium · Canada - Not yet recruitingPHASE2
Study of Zola-cel (BMS-986353), in Participants With Autoimmune Cytopenia (Breakfree-AiCE)
This study is looking at a new medicine called Zola-cel (BMS-986353) for adults with specific blood conditions: chronic immune thrombocytopenia (ITP) and autoimmune hemolytic anemia (AIHA). The goal is to see if it's safe and helps improve these conditions.
For: Chronic Immune Thrombocytopenia · Autoimmune Hemolytic AnemiaUnited States · Denmark · Germany